Literature DB >> 2361796

Aluminum chloride hexahydrate versus palmar hyperhidrosis. Evaporimeter assessment.

C L Goh1.   

Abstract

The efficacy of topical aluminium chloride hexahydrate 20% W/W ethanol (ACH) in the treatment symptomatic palmar hyperhidrosis was studied in 12 patients. A half-sided control single blind (assessor blind) study was done. Patients applied ACH on one palm daily for 4 weeks. The response to treatment was measured objectively with an evaporimeter. There was significant fall of skin water vapor loss (SVL) on treated palms compared with untreated palms. The basal mean SVL of treated palms and untreated palms were 79.9 and 77.9 g water/m2/h, respectively (n.s.). The mean SVLs of treated vs. untreated palms at week 1, 2, 3, and 4 were 66.4 vs. 79.7 (p less than 0.05), 56.6 vs. 72.2 (p less than 0.001), 58.2 vs. 72.5 (p = 0.1), and 51.4 vs. 72.7 (p less than 0.001) g water/m2/h, respectively. The mean SVL of treated palms returned near basal rate within 1 week of stopping treatment. Four patients developed skin irritation from ACH; in three this disappeared after 1 week and they were able to continue with treatment; one withdrew from the study because of the severe irritation. All patients reported that the ACH reduced palmar sweating within 48 hours of application; its effect disappeared within 48 hours after stopping treatment. ACH appeared to be useful in rapid control of palmar hyperhydrosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2361796     DOI: 10.1111/j.1365-4362.1990.tb04766.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 2.  Hyperhidrosis--causes and treatment of enhanced sweating.

Authors:  Tanja Schlereth; Marianne Dieterich; Frank Birklein
Journal:  Dtsch Arztebl Int       Date:  2009-01-16       Impact factor: 5.594

3.  PURLs: Oral agent offers relief from generalized hyperhidrosis

Authors:  Jennie B Jarrett; David Moss
Journal:  J Fam Pract       Date:  2017-06       Impact factor: 0.493

Review 4.  Focal hyperhidrosis: diagnosis and management.

Authors:  Aamir Haider; Nowell Solish
Journal:  CMAJ       Date:  2005-01-04       Impact factor: 8.262

Review 5.  The treatment of primary palmar hyperhidrosis: a review.

Authors:  M Hashmonai; D Kopelman; A Assalia
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

6.  The efficacy and safety of a fractional microneedle radiofrequency device for the treatment of axillary hyperhidrosis: clinical prospective pilot study.

Authors:  Joon Min Jung; Hyoung Min Na; Jung Ho Kim; Jihae Yoon; Hee Joo Yang; Woo Jin Lee; Sung Eun Chang; Mi Woo Lee; Chong Hyun Won
Journal:  Lasers Med Sci       Date:  2021-08-28       Impact factor: 3.161

Review 7.  Current and Emerging Medical Therapies for Primary Hyperhidrosis.

Authors:  Daniel A Grabell; Adelaide A Hebert
Journal:  Dermatol Ther (Heidelb)       Date:  2016-10-27

8.  A systematic evidence-based review of treatments for primary hyperhidrosis.

Authors:  Michael E Stuart; Sheri A Strite; Kristin Khalaf Gillard
Journal:  J Drug Assess       Date:  2020-12-24

9.  A Practical Approach to the Diagnosis and Treatment of Palmar Hyperhidrosis.

Authors:  Max J Solish; Iryna Savinova; Michael J Weinberg
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.